中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2011年
12期
2221-2223
,共3页
戴少军%杨少兵%刘成%李荣春%项红兵
戴少軍%楊少兵%劉成%李榮春%項紅兵
대소군%양소병%류성%리영춘%항홍병
磷脂酰肌醇激酶-3%小干涉RNA%腺病毒科%遗传载体
燐脂酰肌醇激酶-3%小榦涉RNA%腺病毒科%遺傳載體
린지선기순격매-3%소간섭RNA%선병독과%유전재체
Phosphatidylinositol kinase-3%siRNA%Adeno viridae%Genetic vectors
目的 构建磷脂酰肌醇激酶-3 beta(PI3Kcb)基因小干涉RNA (siRNA)的重组35型腺病毒载体( Ad5/F35).方法 在PI3Kcb mRNA序列中选择1个特异性靶序列,体外合成对应发卡样DNA片段,经退火后,将其定向克隆人siRNA载体pDC316-EGFP-U6,获得重组质粒pDC316-PI3Kcb siRNA-EGFP.骨架质粒pBHG-fiber5/35和穿梭质粒pDC316-PI3 Kcb siRNA-EGFP共转染293细胞,同源重组产生Ad5/F35-PI3 Kcb-siRNA.经聚合酶链反应(PCR)鉴定目的基因的表达.结果 PCR表明Ad5/F35-PI3Kcb-siRNA质粒构建正确.结论 获得的Ad5/F35-PI3Kcb-siRNA可以用于转基因疼痛治疗的实验研究.
目的 構建燐脂酰肌醇激酶-3 beta(PI3Kcb)基因小榦涉RNA (siRNA)的重組35型腺病毒載體( Ad5/F35).方法 在PI3Kcb mRNA序列中選擇1箇特異性靶序列,體外閤成對應髮卡樣DNA片段,經退火後,將其定嚮剋隆人siRNA載體pDC316-EGFP-U6,穫得重組質粒pDC316-PI3Kcb siRNA-EGFP.骨架質粒pBHG-fiber5/35和穿梭質粒pDC316-PI3 Kcb siRNA-EGFP共轉染293細胞,同源重組產生Ad5/F35-PI3 Kcb-siRNA.經聚閤酶鏈反應(PCR)鑒定目的基因的錶達.結果 PCR錶明Ad5/F35-PI3Kcb-siRNA質粒構建正確.結論 穫得的Ad5/F35-PI3Kcb-siRNA可以用于轉基因疼痛治療的實驗研究.
목적 구건린지선기순격매-3 beta(PI3Kcb)기인소간섭RNA (siRNA)적중조35형선병독재체( Ad5/F35).방법 재PI3Kcb mRNA서렬중선택1개특이성파서렬,체외합성대응발잡양DNA편단,경퇴화후,장기정향극륭인siRNA재체pDC316-EGFP-U6,획득중조질립pDC316-PI3Kcb siRNA-EGFP.골가질립pBHG-fiber5/35화천사질립pDC316-PI3 Kcb siRNA-EGFP공전염293세포,동원중조산생Ad5/F35-PI3 Kcb-siRNA.경취합매련반응(PCR)감정목적기인적표체.결과 PCR표명Ad5/F35-PI3Kcb-siRNA질립구건정학.결론 획득적Ad5/F35-PI3Kcb-siRNA가이용우전기인동통치료적실험연구.
Objective To construct the recombinant adenovirus' s containing fibers derived from B group serotype 35 (rAd5/F35) vector with phosphatidylinositol kinase-3 catalytic beta polypeptide-siRNA (PI3Kcb-siRNA).Methods A target-specific sequence from PI3Kcb mRNA was used to synthesize the corresponding hairpin DNA fragments in vitro.After annealing,the DNA products were cloned into siRNA vector pDC316-EGFP-U6 to obtain the recombinant siRNA vector plasmid pDC316-PI3Kcb siRNA-EGFP.The 293 cells were cotransfected by the skeleton plasmid of pBHG-fiber5/35 and the shuttle plasmid of pDC316-PDP,and the recombinant plasmid of Ad5/F35-PI3Kcb-siRNA was obtained.The expression of the transfected genes was evaluated by polymerase chain reaction (PCR) and immunocytochemical stain.Results The identification of PCR and immunocytochemical stain showed that the construction of the recombinant Ad5/F35-PI3Kcb-siRNA plasmid could be confirmed.Conclusion The Ad5/F35-PI3Kcb-siRNA vector can be used in empirical study of transgenic pain therapy.